Free Trial

This company has been marked as potentially delisted and may not be actively trading.

AMBI (AMBI) Competitors

AMBI logo

AMBI vs. LICY, CECO, GRC, PRLB, SCSC, ASTE, KRNT, APOG, IPX, and SSYS

Should you be buying AMBI stock or one of its competitors? The main competitors of AMBI include Li-Cycle (LICY), CECO Environmental (CECO), Gorman-Rupp (GRC), Proto Labs (PRLB), ScanSource (SCSC), Astec Industries (ASTE), Kornit Digital (KRNT), Apogee Enterprises (APOG), IperionX (IPX), and Stratasys (SSYS).

AMBI vs. Its Competitors

AMBI (NASDAQ:AMBI) and Li-Cycle (NYSE:LICY) are both small-cap sanitary services industry companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, dividends, earnings, analyst recommendations, profitability, media sentiment, institutional ownership and risk.

AMBI has higher revenue and earnings than Li-Cycle.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AMBI$518.81M0.49$3.44MN/AN/A
Li-Cycle$27.40M0.71-$138M-$1.25-0.67

AMBI has a beta of 0.55, indicating that its stock price is 45% less volatile than the S&P 500. Comparatively, Li-Cycle has a beta of 1.38, indicating that its stock price is 38% more volatile than the S&P 500.

In the previous week, AMBI had 3 more articles in the media than Li-Cycle. MarketBeat recorded 3 mentions for AMBI and 0 mentions for Li-Cycle. AMBI's average media sentiment score of 0.00 equaled Li-Cycle'saverage media sentiment score.

Company Overall Sentiment
AMBI Neutral
Li-Cycle Neutral

Li-Cycle has a consensus target price of $2.25, suggesting a potential upside of 166.90%. Given Li-Cycle's stronger consensus rating and higher possible upside, analysts clearly believe Li-Cycle is more favorable than AMBI.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AMBI
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Li-Cycle
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

26.8% of AMBI shares are held by institutional investors. Comparatively, 54.1% of Li-Cycle shares are held by institutional investors. 52.0% of AMBI shares are held by company insiders. Comparatively, 17.7% of Li-Cycle shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

AMBI has a net margin of 0.00% compared to Li-Cycle's net margin of -77.74%. AMBI's return on equity of 0.00% beat Li-Cycle's return on equity.

Company Net Margins Return on Equity Return on Assets
AMBIN/A N/A N/A
Li-Cycle -77.74%-41.90%-13.43%

Summary

AMBI beats Li-Cycle on 7 of the 12 factors compared between the two stocks.

Get AMBI News Delivered to You Automatically

Sign up to receive the latest news and ratings for AMBI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AMBI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AMBI vs. The Competition

MetricAMBISanitary services IndustryIndustrials SectorNASDAQ Exchange
Market Cap$253.87M$8.01M$7.55B$9.13B
Dividend YieldN/AN/A4.53%4.01%
P/E RatioN/AN/A25.1619.58
Price / Sales0.49N/A113.4079.35
Price / Cash6.40N/A26.5427.50
Price / Book0.93307.004.405.55
Net Income$3.44M-$600K$791.65M$252.19M

AMBI Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AMBI
AMBI
N/A$4.58
-3.6%
N/A+25.8%$253.87M$518.81M0.007,000Gap Up
LICY
Li-Cycle
1.3319 of 5 stars
$0.84
-4.1%
$2.25
+166.9%
-78.4%$19.57M$27.40M-0.67270
CECO
CECO Environmental
3.1632 of 5 stars
$29.61
-0.6%
$36.00
+21.6%
+6.1%$1.04B$608.30M22.951,600Positive News
GRC
Gorman-Rupp
3.6838 of 5 stars
$37.99
+0.3%
N/A-5.3%$998.91M$664.35M22.481,450
PRLB
Proto Labs
1.4159 of 5 stars
$40.78
+0.6%
$43.00
+5.4%
+25.2%$969.38M$499.21M67.972,357
SCSC
ScanSource
3.5197 of 5 stars
$42.13
-0.8%
$42.00
-0.3%
-8.1%$951.97M$2.97B15.212,300News Coverage
Positive News
Analyst Upgrade
ASTE
Astec Industries
0.8256 of 5 stars
$40.74
-2.0%
$41.00
+0.6%
+27.6%$931.60M$1.33B61.734,148
KRNT
Kornit Digital
2.7039 of 5 stars
$19.42
-1.0%
$33.20
+71.0%
+31.1%$923.42M$203.82M-107.88880
APOG
Apogee Enterprises
3.8245 of 5 stars
$42.38
+0.6%
$45.00
+6.2%
-27.9%$914.26M$1.38B18.114,500
IPX
IperionX
0.8617 of 5 stars
$28.17
+1.1%
$28.00
-0.6%
+121.3%$899.07MN/A0.00N/APositive News
Gap Down
SSYS
Stratasys
1.4887 of 5 stars
$11.58
-1.4%
$12.20
+5.4%
+22.6%$830.52M$572.46M-7.721,779

Related Companies and Tools


This page (NASDAQ:AMBI) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners